CN104840655A - Pharmaceutical preparation for treating tuberculous peritonitis - Google Patents
Pharmaceutical preparation for treating tuberculous peritonitis Download PDFInfo
- Publication number
- CN104840655A CN104840655A CN201510309978.0A CN201510309978A CN104840655A CN 104840655 A CN104840655 A CN 104840655A CN 201510309978 A CN201510309978 A CN 201510309978A CN 104840655 A CN104840655 A CN 104840655A
- Authority
- CN
- China
- Prior art keywords
- parts
- pharmaceutical preparation
- radix
- tuberculous peritonitis
- peritonitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the field of drugs, and provides a pharmaceutical preparation for treating tuberculous peritonitis. The pharmaceutical preparation for treating tuberculous peritonitis is prepared from the following raw materials in parts by weight: 20 parts of pedunculate acronychia wood, 15 parts of alderleaf sida root, 16 parts of euphorbia lunulata, 18 parts of wight anotis, 18 parts of Chinese honeylocust spine, 20 parts of banyan bark, 16 parts of rhizoma calami, 17 parts of leaf of manynerve bauhinia, 20 parts of radix fici simplicissimae root, 18 parts of harlequin glorybower root and 20 parts of sharptooth incarvillea rhizome and herb. The pharmaceutical preparation has a function of treating tuberculous peritonitis.
Description
Technical field
The present invention relates to technical field of pharmaceuticals, be specifically related to a kind of pharmaceutical preparation and the preparation method and application that treat tuberculous peritonitis.
Background technology
Tuberculous peritonitis is that the peritoneum caused by tubercule bacillus is chronic, diffuse inflammation, and tulase belongs to Actinomycetal, the Mycobacterium of mycobacteriaceae, for there being the acid fast bacteria of pathogenicity, mainly divides for the types such as people, cattle, bird, Mus.Pathogenic person mainly human-like bacterium is had, the rare infection of cattle type bacterium to people.Human-like is all obligate parasite with bovine tuberculosis bacterial strain, respectively with people and cattle for natural host.Both have the pathogenicity of equality strength to people, monkey and Cavia porcellus.Lack effective medicine at present.
Summary of the invention
Goal of the invention: in order to solve the problem, the object of the present invention is to provide a kind of pharmaceutical preparation and the preparation method and application that treat tuberculous peritonitis.
Technical scheme: the object of the invention is by following scheme realize:
Treat a pharmaceutical preparation for tuberculous peritonitis, it is prepared by the raw material of following parts by weight: Lignum seu Radix Acronychiae 20 parts, Radix sidae alnifoliae 15 parts, Herba euphorbiae lunulatae 16 parts, Anotis wightiana (Wall.) Hook.F. 18 parts, Spina Gleditsiae 18 parts, Cortex fici microcarpae 20 parts, Rhizoma Acori Calami 16 parts, Folium Bauhiniae pernervosae 17 parts, Radix Fici Simplicissimae 20 parts, Radix clerodendri trichotomi 18 parts, Herba Incarvilleae argutae 20 parts.
The application of pharmaceutical preparation in preparation treatment tuberculous peritonitis medicine of described treatment tuberculous peritonitis.
In the present invention, Lignum seu Radix Acronychiae is heartwood or the root of rutaceae Acronychi apedunculata (L.) Miq..Radix sidae alnifoliae is the root of the little Radix Bupleuri of Malvaceae plant.Herba euphorbiae lunulatae is the herb of euphorbia plant Herba euphorbiae lunulatae.Anotis wightiana (Wall.) Hook.F. is the herb of the false Auricled Hedyotis Herb of Maguireothamnus speciosus point leaf.Spina Gleditsiae is the Spina jujubae of leguminous plant Fructus Gleditsia.Cortex fici microcarpae is the bark of moraceae plants Ficus microcarpa Linn. f.Rhizoma Acori Calami is the rhizome of aroid Rhizoma Acori Calami AcoruscalamusL..Folium Bauhiniae pernervosae is the leaf of leguminous plant many arteries and veins leaf Bauhinia purpurea.Radix Fici Simplicissimae is the root of moraceae plants ficus simplicissima.Radix clerodendri trichotomi is the root of Verbenaceae Folium et Ramulus Clerodendri Trichotomi.Herba Incarvilleae argutae is the herb of Bignoniaceae plant Herba Melicae Scabrosae.
Beneficial effect:
Lignum seu Radix Acronychiae of the present invention, Radix sidae alnifoliae, Herba euphorbiae lunulatae, Anotis wightiana (Wall.) Hook.F., Spina Gleditsiae, Cortex fici microcarpae, Rhizoma Acori Calami, Folium Bauhiniae pernervosae, Radix Fici Simplicissimae, Radix clerodendri trichotomi, Herba Incarvilleae argutae removing summer-heat poison, blood circulation promoting and blood stasis dispelling, inducing diuresis to remove edema, invigorating the spleen and replenishing QI, obtained medicine can safe and effective treatment tuberculous peritonitis.
Detailed description of the invention
Form by the following examples, foregoing of the present invention is described in further detail again, but this should be interpreted as that the scope of the above-mentioned theme of the present invention is only limitted to following example, all technology realized based on foregoing of the present invention all belong to scope of the present invention.
1, specific embodiment 1: take Lignum seu Radix Acronychiae 20g, Radix sidae alnifoliae 15g, Herba euphorbiae lunulatae 16g, Anotis wightiana (Wall.) Hook.F. 18g, Spina Gleditsiae 18g, Cortex fici microcarpae 20g, Rhizoma Acori Calami 16g, Folium Bauhiniae pernervosae 17g, Radix Fici Simplicissimae 20g, Radix clerodendri trichotomi 18g, Herba Incarvilleae argutae 20g, add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, dry, add starch, granulate according to a conventional method, fill, be prepared into hard capsule, the capsule of adult normal's 1 day consumption must be met.Be used for the treatment of tuberculous peritonitis.Oral, every bu is taken for twice sooner or later.
2, specific embodiment 2: take Lignum seu Radix Acronychiae 20g, Radix sidae alnifoliae 15g, Herba euphorbiae lunulatae 16g, Anotis wightiana (Wall.) Hook.F. 18g, Spina Gleditsiae 18g, Cortex fici microcarpae 20g, Rhizoma Acori Calami 16g, Folium Bauhiniae pernervosae 17g, Radix Fici Simplicissimae 20g, Radix clerodendri trichotomi 18g, Herba Incarvilleae argutae 20g, add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, dry, add starch, granulate according to a conventional method, be prepared into granule, the granule of adult normal's 1 day consumption must be met.Be used for the treatment of tuberculous peritonitis.Oral, every bu is taken for twice sooner or later.
3, specific embodiment 3: take Lignum seu Radix Acronychiae 20g, Radix sidae alnifoliae 15g, Herba euphorbiae lunulatae 16g, Anotis wightiana (Wall.) Hook.F. 18g, Spina Gleditsiae 18g, Cortex fici microcarpae 20g, Rhizoma Acori Calami 16g, Folium Bauhiniae pernervosae 17g, Radix Fici Simplicissimae 20g, Radix clerodendri trichotomi 18g, Herba Incarvilleae argutae 20g, add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, dry, add starch, granulate according to a conventional method, tabletting, the tablet of adult normal's 1 day consumption must be met.Be used for the treatment of tuberculous peritonitis.Oral, every bu is taken for twice sooner or later.
4, the present invention is to the clinical research of tuberculous peritonitis
4.1, physical data: inventor's in JIUYUE, 2012 collects the out-patient of 60 routine tuberculous peritonitis altogether between in February ,-2014, age 19-37 year, course of disease 1-2.Be divided at random: treatment group 30 example, blank group 30 example.The two groups of data such as age, state of an illness there was no significant differences, have comparability.
Diagnostic criteria:
(1) agnogenic heating, continues more than two weeks, with night sweat, invalid through general antibiotic therapy.
(2) there is tuberculosis close contact history or have the outer tuberculosis person of other intestinal in person.
(3) pliable and tough sensation of abdominal wall, has the ascites person that maybe can touch enclosed mass.
(4) erythrocyte sedimentation rate speedup, ascites is transudate person.
(5) x-ray barium meal examination of gastro-intestinal tract finds the sign persons such as intestinal adhesion.
4.2, test method
4.2.1 the oral the present invention for the treatment of group is according to the obtained granule of specific embodiment 2, sooner or later each once.15 days courses for the treatment of.
4.2.2 blank group oral placebo granule, sooner or later respectively once.15 days courses for the treatment of.
4.3, criterion of therapeutical effect and therapeutic outcome
4.3.1 criterion of therapeutical effect
Recovery from illness: clinical symptoms all disappears, and test chamber inspection is normal.Take a turn for the better: clinical symptom relief, the state of an illness is controlled, lab testing improvement or normal.Invalid: clinical symptoms is without being clearly better or increasing the weight of.
4.3.2 statistical result is treated in table 1.
Table 1 liang group comparitive study
| Group | n | Recovery from illness | Take a turn for the better | Invalid | Total effective rate (%) |
| Treatment group | 30 | 10 | 18 | 2 | 93.3 |
| Blank group | 30 | 0 | 1 | 29 | 3.33 |
Visible, the medicine that the present invention obtains can safe and effective treatment tuberculous peritonitis, and has no side effect.
Claims (2)
1. treat the pharmaceutical preparation of tuberculous peritonitis for one kind, it is characterized in that, it is prepared by the raw material of following parts by weight: Lignum seu Radix Acronychiae 20 parts, Radix sidae alnifoliae 15 parts, Herba euphorbiae lunulatae 16 parts, Anotis wightiana (Wall.) Hook.F. 18 parts, Spina Gleditsiae 18 parts, Cortex fici microcarpae 20 parts, Rhizoma Acori Calami 16 parts, Folium Bauhiniae pernervosae 17 parts, Radix Fici Simplicissimae 20 parts, Radix clerodendri trichotomi 18 parts, Herba Incarvilleae argutae 20 parts.
2. treat the application of pharmaceutical preparation in treatment tuberculous peritonitis medicine of tuberculous peritonitis as claimed in claim 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510309978.0A CN104840655A (en) | 2015-06-03 | 2015-06-03 | Pharmaceutical preparation for treating tuberculous peritonitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510309978.0A CN104840655A (en) | 2015-06-03 | 2015-06-03 | Pharmaceutical preparation for treating tuberculous peritonitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104840655A true CN104840655A (en) | 2015-08-19 |
Family
ID=53840901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510309978.0A Withdrawn CN104840655A (en) | 2015-06-03 | 2015-06-03 | Pharmaceutical preparation for treating tuberculous peritonitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104840655A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102940815A (en) * | 2012-11-30 | 2013-02-27 | 胡斌 | Medicine prescription for treating tuberculosis and tuberculous rheumatism |
| CN104306837A (en) * | 2014-08-06 | 2015-01-28 | 张立梅 | Baibei anti-tuberculosis pill for treating pulmonary tuberculosis, tuberculous pleuritis, peritonitis, empyema and bronchopleural fistula |
-
2015
- 2015-06-03 CN CN201510309978.0A patent/CN104840655A/en not_active Withdrawn
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102940815A (en) * | 2012-11-30 | 2013-02-27 | 胡斌 | Medicine prescription for treating tuberculosis and tuberculous rheumatism |
| CN104306837A (en) * | 2014-08-06 | 2015-01-28 | 张立梅 | Baibei anti-tuberculosis pill for treating pulmonary tuberculosis, tuberculous pleuritis, peritonitis, empyema and bronchopleural fistula |
Non-Patent Citations (1)
| Title |
|---|
| 王玉贤: "《难病奇方系列丛书 增液汤》", 31 January 2013, 中国医药科技出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101293065B (en) | Biological proprietary Chinese medicine for preventing and treating diabetes | |
| CN102671088A (en) | Traditional Chinese medicine combination for treating tuberculosis | |
| CN104258091A (en) | Traditional Chinese medicine composition for treating fatty liver as well as preparation method and application of traditional Chinese medicine composition | |
| CN104840655A (en) | Pharmaceutical preparation for treating tuberculous peritonitis | |
| CN103656302B (en) | One treats pertussal Chinese herbal medicine granule and preparation method thereof | |
| CN101085048B (en) | Traditional Chinese medicine for detoxicating for animals and preparation method thereof | |
| CN103860786A (en) | Medicine for treating puerperal fever | |
| CN103800844B (en) | A kind of pharmaceutical composition for the treatment of acute pancreatitis and preparation method thereof | |
| CN104825651A (en) | Traditional Chinese medicine composition for treating rheumatic arthralgia | |
| CN104524443A (en) | Traditional Chinese medicine composition for hypomenorrhea | |
| CN104857489A (en) | Medicinal preparation for curing periarthritis of shoulder | |
| Liu et al. | Efficacy and safety of herbal medicine (Binafuxi granules) for the common cold with fever: A multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial | |
| CN105012808A (en) | Medicinal preparation for treating gout | |
| CN105412397A (en) | Traditional Chinese medicine for treating chronic pyothorax and preparation method of traditional Chinese medicine | |
| CN104524307A (en) | Traditional Chinese composition for treating emesis and preparation method and application | |
| CN104398854A (en) | Chinese medicinal composition for treatment of vertigo, preparation method and application | |
| CN104274512A (en) | Traditional Chinese medicine for treatment of chronic atrophic gastritis | |
| CN102389509B (en) | Traditional Chinese medicinal composition for treating HIV and preparation method thereof | |
| CN108685984A (en) | A kind of drug for treating chordapsus | |
| CN103830611B (en) | A kind of Chinese medicine for the treatment of measles complicated by pneumonia pattern of syndrome pneumonia | |
| CN111743977A (en) | A Chinese medicinal composition for preventing and treating pneumonia and its preparation method | |
| CN111568980A (en) | Chinese medicinal preparation for dispelling wind and eliminating dampness and preparation method thereof | |
| CN106074970A (en) | A kind of Yishen Huoxue clear network prescription and instructions of taking thereof | |
| CN105169353A (en) | Traditional Chinese medicine for treating secretory otitis media | |
| CN104800534A (en) | Chinese medicinal composition for treating perennial allergic rhinitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20150819 |
|
| WW01 | Invention patent application withdrawn after publication |